Our top priority is people's health

Our top priority is the health of the people of Belarus. We make a significant contribution to providing the populations of Belarus and other countries with affordable and effective medicines.

We are growing to ensure that state-of-the-art, high-quality, and effective medicines are accessible.

Our goals for 2026:

• 30+ new product registrations;
• 50+ drugs in active development;
• launch of a beta-lactam antibiotic line and a biopharmaceuticals unit;
• development of solid and liquid anticancer drug production;
• launch of three active pharmaceutical ingredient (API) production units;
• GMP certification of a major sterile lyophilized dosage form unit;
• establishment of a new sterile products facility;
• exports to Russia, Uzbekistan, Azerbaijan, Kyrgyzstan, Tajikistan, Turkmenistan, and others.